Logo

The US FDA Authorizes the Emergency Use of Antimalarial Drugs to Combat COVID-19

Share this

The US FDA Authorizes the Emergency Use of Antimalarial Drugs to Combat COVID-19

Shots:

  • The US FDA has issued the EUA to the hydroxychloroquine and chloroquine products donated to the Strategic National Stockpile (SNS) to be distributed and utilized to treat patients with COVID-19
  • The SNS will distribute anti-malarial drugs to the states for doctors to prescribe it to adolescent and adult patients hospitalized with COVID-19 and who cannot be part of clinical studies
  • The SNS will work with FEMA for donating doses to the states. Additionally- the EUA requires fact sheets- providing information regarding the anti-malarial therapies in treating COVID-19 to be made available to HCPs and patients- including the risks and drug interactions associated with the drugs

Click here to­ read full press release/ article | Ref: FDA | Image: Pink Sheet


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions